Skip to main content
Top
Published in: Trials 1/2017

Open Access 01-12-2017 | Research

Subversion of allocation concealment in a randomised controlled trial: a historical case study

Authors: Andrew D. M. Kennedy, David J. Torgerson, Marion K. Campbell, Adrian M. Grant

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

If the randomisation process within a trial is subverted, this can lead to selection bias that may invalidate the trial’s result. To avoid this problem, it is recommended that some form of concealment should be put into place. Despite ongoing anecdotal concerns about their susceptibility to subversion, a surprising number of trials (over 10%) still use sealed opaque envelopes as the randomisation method of choice. This is likely due in part to the paucity of empirical data quantifying the potential effects of subversion. In this study we report a historical before and after study that compares the use of the sealed envelope method with a more secure centralised telephone allocation approach in order to provide such empirical evidence of the effects of subversion.

Methods

This was an opportunistic before and after study set within a multi-centre surgical trial, which involved 654 patients from 28 clinicians from 23 centres in the UK and Ireland. Two methods of randomly allocating subjects to alternative treatments were adopted: (a) a sealed envelope system administered locally, and (b) a centralised telephone system administered by the trial co-ordination centre. Key prognostic variables were compared between randomisation methods: (a) age at trial entry, a key prognostic factor in the study, and (b) the order in which ‘randomisation envelopes’ were matched to subjects.

Results

The median age of patients allocated to the experimental group with the sealed envelope system, was significantly lower both overall (59 vs 63 years, p < 0.01) and in particular for three clinicians (57 vs 72, p < 0.01; 33 vs 69, p < 0.001; 47 vs 72, p = 0.03). No differences in median age were found between the allocation groups for the centralised system.

Conclusions

Due to inadequate allocation concealment with the sealed envelope system, the randomisation process was corrupted for patients recruited from three clinicians. Centralised randomisation ensures that treatment allocation is not only secure but seen to be secure. Where this proves to be impossible, allocation should at least be performed by an independent third party. Unless it is an absolute requirement, the use of sealed envelopes should be discontinued forthwith.
Literature
1.
3.
go back to reference Chalmers TC, et al. Bias in treatment assignment in controlled clinical trials. NEJM. 1983;309:1358–61.CrossRefPubMed Chalmers TC, et al. Bias in treatment assignment in controlled clinical trials. NEJM. 1983;309:1358–61.CrossRefPubMed
4.
go back to reference Altman, DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990;335:149–53. Altman, DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990;335:149–53.
5.
6.
go back to reference Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–12.CrossRefPubMed Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–12.CrossRefPubMed
8.
go back to reference Berger VW. Selection bias and covariate imbalances in randomized clinical trials. Chichester: John Wiley & Sons Ltd; 2005.CrossRef Berger VW. Selection bias and covariate imbalances in randomized clinical trials. Chichester: John Wiley & Sons Ltd; 2005.CrossRef
9.
go back to reference Brown S, Thorpe H, Hawkins K, Brown J. Minimization – reducing predictability for multi-centre trials whilst retaining balance with centre. Stat Med. 2005;24:3715–27.CrossRefPubMed Brown S, Thorpe H, Hawkins K, Brown J. Minimization – reducing predictability for multi-centre trials whilst retaining balance with centre. Stat Med. 2005;24:3715–27.CrossRefPubMed
10.
go back to reference Clark L, Fairhurst C, Torgerson DJ. Allocation concealment in randomised controlled trials: could do better. BMJ. 2016;315:i5663.CrossRef Clark L, Fairhurst C, Torgerson DJ. Allocation concealment in randomised controlled trials: could do better. BMJ. 2016;315:i5663.CrossRef
11.
go back to reference Hewitt C, Hahn S, Torgerson DJ, Watson J, Bland JM. Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals. BMJ. 2005;330:1057–8.CrossRefPubMedPubMedCentral Hewitt C, Hahn S, Torgerson DJ, Watson J, Bland JM. Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals. BMJ. 2005;330:1057–8.CrossRefPubMedPubMedCentral
12.
go back to reference Pocock S. Clinical trials: A practical approach. Chichester: Wiley; 1983. Pocock S. Clinical trials: A practical approach. Chichester: Wiley; 1983.
13.
go back to reference Berger VW, Exner DV. Detecting selection bias in randomized clinical trials. Control Clin Trials. 1999;20:319–27.CrossRefPubMed Berger VW, Exner DV. Detecting selection bias in randomized clinical trials. Control Clin Trials. 1999;20:319–27.CrossRefPubMed
14.
go back to reference Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, et al. CONSORT 2010 Explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;240:c869.CrossRef Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, et al. CONSORT 2010 Explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;240:c869.CrossRef
15.
go back to reference Turner J, Russell D, Russell I, Gemmell LW, France B, Bride M, Edwards AE. Baseline imbalance in a randomised trial: a cautionary tale. Care Critically Ill. 2006;22(2):1–4. Turner J, Russell D, Russell I, Gemmell LW, France B, Bride M, Edwards AE. Baseline imbalance in a randomised trial: a cautionary tale. Care Critically Ill. 2006;22(2):1–4.
Metadata
Title
Subversion of allocation concealment in a randomised controlled trial: a historical case study
Authors
Andrew D. M. Kennedy
David J. Torgerson
Marion K. Campbell
Adrian M. Grant
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-1946-z

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue